Theravance Biopharma Stock Target Price and Analyst Consensus
TBPH Stock | USD 9.01 0.19 2.15% |
The current analyst and expert consensus on Theravance Biopharma is Buy, with 1 strong buy opinions. The current projected Theravance Biopharma target price consensus is 13.4 with 4 analyst opinions. The most common way Theravance Biopharma analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Theravance Biopharma executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Theravance Biopharma. We encourage you to use your own analysis of Theravance Biopharma to validate this buy or sell advice. Theravance Biopharma buy-or-sell recommendation module provides average expert sentiment on the projected Theravance Biopharma target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Theravance Biopharma to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more detail on how to invest in Theravance Stock please use our How to Invest in Theravance Biopharma guide.
Lowest Forecast 12.19 | Highest Forecast 14.87 | Target Price 13.4 |
Theravance |
It's important to approach Theravance Biopharma's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Theravance Biopharma Target Price Consensus
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Theravance target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Theravance Biopharma's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
4 | Buy |
Most Theravance analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Theravance stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Theravance Biopharma, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationTheravance Biopharma Target Price Projection
Theravance Biopharma's current and average target prices are 9.01 and 13.40, respectively. The current price of Theravance Biopharma is the price at which Theravance Biopharma is currently trading. On the other hand, Theravance Biopharma's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Theravance Biopharma Market Quote on 28th of March 2024
Target Price
Analyst Consensus On Theravance Biopharma Target Price
Theravance Biopharma Analyst Ratings
Theravance Biopharma's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Theravance Biopharma stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Theravance Biopharma's financials, market performance, and future outlook by experienced professionals. Theravance Biopharma's historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Theravance Biopharma price targets
Theravance Biopharma's stock target price is an estimate of its future price, usually made by analysts. Using Theravance Biopharma's target price to determine if it is a suitable investment can be done through the following steps:- Look at Theravance Biopharma's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Theravance Biopharma's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Theravance Biopharma Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Theravance Biopharma is a key component of Theravance Biopharma valuation and have some predictive power on the future returns of a Theravance Biopharma.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Theravance Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.Artificial Intelligence Invested few shares | ||
Driverless Cars Invested a lot of shares | ||
Business Services Invested over 100 shares | ||
Macroaxis Index Invested few shares | ||
Banking Invested over 40 shares | ||
Hedge Favorites Invested few shares | ||
Check out Macroaxis Advice on Theravance Biopharma to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more detail on how to invest in Theravance Stock please use our How to Invest in Theravance Biopharma guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for Theravance Stock analysis
When running Theravance Biopharma's price analysis, check to measure Theravance Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theravance Biopharma is operating at the current time. Most of Theravance Biopharma's value examination focuses on studying past and present price action to predict the probability of Theravance Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theravance Biopharma's price. Additionally, you may evaluate how the addition of Theravance Biopharma to your portfolios can decrease your overall portfolio volatility.
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
The data published in Theravance Biopharma's official financial statements usually reflect Theravance Biopharma's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Theravance Biopharma. For example, before you start analyzing numbers published by Theravance accountants, it's critical to develop an understanding of what Theravance Biopharma's liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of Theravance Biopharma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Theravance Biopharma's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Theravance Biopharma's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Theravance Biopharma. Please utilize our Beneish M Score to check the likelihood of Theravance Biopharma's management manipulating its earnings.